Overactive Bladder/Enuresis Archives - Page 15 of 16 - Renal and Urology News

Overactive Bladder/Enuresis

Experimental Agent Ameliorates OAB

MILAN—New data demonstrate that the investigational agent fesoterodine, at both the 4 or 8 mg per day dose, is associated with significant improvements in overactive bladder (OAB) symptoms.

Next post in News